Replies to post #394489 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Milgarde, I’m still paying attention. It would be smarter to use ESMO, only so so smart to use SNO.

As we slip though Sep the focus will shirt to SNO.

Once SNO comes up with nothing, then the ASM. And as that gets close, ASCO.

Pattern repeats every year.

When will be the first post about a big booth at ASCO 2022?